THE NEW FUND INSTITUTE FOR COLLABO… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2014

Legal Domicile

Principal Officer

DUNCAN DARROW

Phone

6313240405

Tax Period

2019-01-01 to 2019-12-31

THE NEW FUND INSTITUTE FOR COLLABOR CANCER RESEARCH INC, founded in 2014, is a micro nonprofit that reported $5K in total revenue in fiscal year 2019. Revenue decreased 12% compared to the prior year. Expenses of $247K exceeded revenue, resulting in a 4648% operating deficit.

Mission

TO FUND SCIENTIFIC AND MEDICAL RESEARCH IN THE DISCOVERY AND DEVELOPMENT OF NEW MEDICINES FOR TREATING CANCER.

Program Service Accomplishments

Program 1

Expenses: $168,318

FUNDING SCIENTIFIC AND MEDICAL RESEARCH FOR THE DISCOVERY AND DEVELOPMENT OF NEW MEDICINES IN TREATING CANCER.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2019)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $0

Investment Income $5,203

Other Revenue $0

TOTAL REVENUE $5,203

Expense Breakdown

Grants Paid $0

Salaries & Benefits $207,130

Fundraising Expenses $0

Program Expenses $168,318

Other Expenses $39,909

TOTAL EXPENSES $247,039

Year-over-Year Comparison

	2019	2018	Change
Revenue	$5,203	$5,882	-0.1%
Expenses	$247,039	$308,908	-0.2%
Net Income	$-241,836	$-303,026	-0.2%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$200,000

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
DUNCAN DARROW	Chairman	40.00	Officer	$200,000	$0	$200,000
MARK PASSMANTIER MD	Director	1.00	Officer	$0	$0	$0
ALAN JAKIMO	Director	1.00	Officer	$0	$0	$0
JEREMY BLOOMER	COO	1.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2019	$5,203	$247,039	$254,883	$-241,836
2018	$5,882	$308,908	$484,717	$-303,026

THE NEW FUND INSTITUTE FOR COLLABOR CANCER RESEARCH INC